Jacobs Levy Equity Management
LOXO

Jacobs Levy Equity Management’s Loxo Oncology, Inc LOXO Stock Holding History

Jacobs Levy Equity Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,360
Closed -$232K – 1126
2018
Q3 		$232K Buy
+1,360
New +$229K ﹤0.01% 909

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management's LOXO Position: Q4 2018 in Review

Jacobs Levy Equity Management sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 1,360 shares — an estimated $232K sold.

Jacobs Levy Equity Management first reported a position in LOXO in Q3 2018 and held it in 1 quarter. The position peaked at $232K in Q3 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Jacobs Levy Equity Management reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 1,360 Loxo Oncology, Inc shares in Q4 2018, an estimated $232K.
  • Jacobs Levy Equity Management first reported a position in Loxo Oncology, Inc in Q3 2018 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Loxo Oncology, Inc position peaked at $232K in Q3 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.